A Study to Assess Persistence, Adherence and Changes in Disease Activity in the Children Population of Juvenile Arthritis Patients Treated With Adalimumab (HUMIRA®)

Study Identifier
P17-164
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Juvenile Idiopathic Arthritis
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    2 - 18 Years

    Protocol Summary

    The objective of this study is to assess persistence, adherence and changes in disease activity in the children population of juvenile arthritis patients treated with adalimumab (HUMIRA®) in the routine clinical settings in the Russian Federation.

    Study Locations

    Location
    Status
    Location
    Republican Children's Clinical Hospital /ID# 204830
    Ufa, Bashkortostan Republic, Russian Federation, 450106
    Status
    Not applicable
    Location
    Chelyabinsk Regional Children's Clinical Hospital /ID# 204829
    Chelyabinsk, Chelyabinsk Oblast, Russian Federation, 454087
    Status
    Not applicable
    Location
    Saratov State Medical University n.a. V.I. Razumovskiy /ID# 206319
    Saratov, Saratov Oblast, Russian Federation, 410012
    Status
    Not applicable
    Location
    Kazan State Medical Academy /ID# 207004
    Kazan', Russian Federation, 420012
    Status
    Not applicable
    Location
    Morozovskaya Children's City Clinical Hospital /ID# 207006
    Moscow, Russian Federation, 119049
    Status
    Not applicable
    Location
    Sechenov First Moscow Medical /ID# 207005
    Moscow, Russian Federation, 119992
    Status
    Not applicable
    Showing {first} - {last} of {total} Results